0 results available. Select is focused ,type to refine list, press Down to open the menu,
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and int...
The following section summarizes insights on Glaukos Corp's Float Shares / Outstanding:
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Float Shares / Outstanding in the valuation category include:
The percentage of outstanding shares that are available for trading.
Float Shares / Outstanding
The float is the number of shares actually available for trading. Shares outstanding are all the shares of a corporation or financial asset that have been authorized, issued and purchased by investors and are held by them. Float Shares / Outstanding measure the percentage of outstanding shares that are available for trading:
% Float = Float Shares / Shares Outstanding
The chart above depicts the distribution of float shares / outstanding for companies operating in the Healthcare sector in the Developed economic region. Over 2,305 companies were considered in this analysis, and 2,218 had meaningful values. The average float shares / outstanding of companies in the sector is 66.9% with a standard deviation of 23.4%.
Glaukos Corp's Float Shares / Outstanding of 96.7% ranks in the 89.4% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,310 |
| Included Constituents | 2,218 |
| Min | 13.0% |
| Max | 99.8% |
| Median | 70.1% |
| Mean | 66.9% |
| Standard Deviation | 23.4% |
You can find companies with similar float shares / outstanding using this stock screener.